The global oral thin films industry is entering a period of strong expansion as pharmaceutical manufacturers and healthcare providers increasingly prioritize patient-centric drug delivery systems that combine convenience, rapid administration, and improved medication adherence. Oral thin films are ultra-thin drug delivery strips designed to dissolve rapidly in the mouth and deliver active pharmaceutical ingredients through buccal or sublingual routes. Unlike conventional tablets and capsules, these dosage forms can often be administered without water, making them particularly useful for children, elderly patients, individuals with dysphagia, and patients who have difficulty swallowing conventional solid medicines.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42869

The global oral thin films industry was valued at US$ 3.8 Bn in 2024 and is projected to grow at a CAGR of 8.2% from 2025 to 2035, crossing US$ 9.0 Bn by the end of 2035. Analysts attribute this expansion to rising demand for convenient dosage forms, increasing chronic disease prevalence, improvements in polymer and formulation technologies, and growing investment in advanced drug delivery platforms. The market is also benefiting from expanding applications across pain management, anti-nausea treatments, vitamins, supplements, and over-the-counter medicines.

Market Size and Growth

Market growth is being supported by the increasing emphasis on medication adherence and improved patient experience. Conventional oral dosage forms can present challenges for patients who require frequent medication, dislike swallowing tablets, or do not have convenient access to water. Oral thin films address these limitations through their compact, portable, and rapidly dissolving format. Sublingual films can enable rapid drug absorption through the tissues beneath the tongue, while buccal films can provide more prolonged delivery through the mucosal lining of the cheek. These characteristics make oral films attractive for therapeutic areas in which rapid onset or controlled exposure is important. Technological advances are further improving the ability of manufacturers to incorporate different active pharmaceutical ingredients into stable film matrices, including APIs that may otherwise present challenges relating to solubility, dosage precision, or conventional formulation. Increasing pharmaceutical R&D expenditure, product innovation, and the development of more sophisticated manufacturing processes are expected to support sustained market growth through 2035.

Market Segmentation

By product type, the global oral thin films market includes sublingual films, buccal films, and fast-dissolving oral films. Sublingual films held a leading position in 2024, supported by their rapid dissolution and direct absorption into systemic circulation. This characteristic is particularly valuable for medicines requiring fast therapeutic action, including certain analgesics and emergency treatments. Fast-dissolving films are also gaining attention because they disintegrate quickly without requiring water and can be formulated for prescription, over-the-counter, vitamin, and supplement applications. Buccal films, meanwhile, provide opportunities for sustained drug release and localized or systemic delivery across the buccal mucosa. By application, oral thin films are used across pain management, anti-emetic therapy, vitamins and supplements, and other therapeutic categories. Distribution channels are also evolving, with pharmacies, hospitals, clinics, retail outlets, and increasingly e-commerce and direct-to-consumer platforms contributing to market access. Digital health education and online purchasing are creating additional opportunities for manufacturers to reach consumers seeking convenient healthcare products.

Key Market Drivers

Convenience and Ease of Use

Convenience is one of the strongest factors driving adoption of oral thin films. Patients can place the film in the mouth and allow it to dissolve without needing water, simplifying medication administration in everyday situations. This feature is particularly advantageous for children, older adults, individuals with swallowing difficulties, and people who travel or work in environments where conventional medication administration is inconvenient. The lightweight and discreet format also allows patients to carry doses easily in pockets, purses, or bags. For medicines intended to provide rapid relief, quick dissolution can further enhance the perceived benefits of the dosage form by supporting a potentially faster onset of action.

Growing Demand for Patient-Centric Drug Delivery

The pharmaceutical industry is increasingly moving toward treatment approaches that consider patient preferences, comfort, adherence, and lifestyle. The growing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and other long-term conditions has increased the need for dosage forms that patients can use consistently over extended treatment periods. Oral thin films can contribute to this objective by simplifying administration and offering opportunities for taste masking, flavor customization, and precise dosing. Their flexibility in incorporating different APIs and formulation components also provides manufacturers with opportunities to develop products tailored to specific patient populations.

Regional Analysis

North America dominated the global oral thin films market in 2024 and is expected to maintain a significant position during the forecast period. The region benefits from advanced healthcare infrastructure, substantial pharmaceutical R&D investment, strong adoption of innovative drug delivery technologies, and a high prevalence of chronic diseases. These factors create favorable conditions for the development and commercialization of oral thin film products. The growing focus on patient-centered healthcare is also encouraging pharmaceutical companies to explore less invasive and more convenient alternatives to conventional dosage forms. Regulatory support for innovative drug delivery technologies, combined with strong healthcare spending and consumer awareness, is expected to sustain regional demand. Meanwhile, Europe and Asia Pacific are anticipated to provide significant growth opportunities as pharmaceutical manufacturing capabilities expand, healthcare expenditure increases, and awareness of advanced drug delivery technologies rises.

Competitive Landscape

The competitive landscape of the oral thin films market is characterized by continuous product development, formulation innovation, manufacturing improvements, and strategic collaborations. Leading companies are investing in R&D to improve film stability, drug loading, absorption, taste, dissolution characteristics, and manufacturing efficiency. Companies are also exploring advanced polymer technologies capable of accommodating APIs with challenging physicochemical properties. The competitive environment is further influenced by partnerships between pharmaceutical companies, technology providers, and specialized drug delivery developers. The development of digitally enabled or “smart” film technologies represents an emerging area of innovation, with potential applications in medication adherence monitoring and personalized treatment. Key players operating in the global oral thin films market include Aquestive Therapeutics, Inc., ARx, LLC, ZIM LABORATORIES LIMITED, LTS Lohmann Therapie-Systeme AG, Nova Thin Film Pharmaceuticals LLC, Corium Innovations, Inc., CD Formulation, Viatris Inc., C.L. Pharm, Cure Pharmaceutical, Indivior plc, DK Livkon Pvt. LTD., NAL Pharma, Shilpa Therapeutics Pvt. Ltd., and Flagship Biotech International Pvt. Ltd.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453